BAROnova Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Out of Business

BAROnova General Information

Description

Developer of nonmedical devices designed to help patients in managing their weight. The company's devices are inserted into the stomach through the mouth using a simple endoscopic procedure that causes a patient's stomach to fill up faster, stay full longer, and potentially delay gastric emptying, enabling patients to reduce weight.

Contact Information

Website
baronovainc.com
Formerly Known As
Polymorfix
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1551 Industrial Road
  • San Carlos, CA 94070
  • United States
Primary Industry
Therapeutic Devices
Vertical(s)
Life Sciences
Corporate Office
  • 1551 Industrial Road
  • San Carlos, CA 94070
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BAROnova Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Out of Business 25-Feb-2025 Completed Out of Business
10. Secondary Transaction - Private 24-Jun-2022 Completed Clinical Trials - Phase 2
9. Secondary Transaction - Private Completed Clinical Trials - Phase 2
8. Later Stage VC (Series E) 05-Feb-2019 Completed Clinical Trials - Phase 2
7. Later Stage VC (Series D) 23-Aug-2017 Completed Clinical Trials - General
6. Debt - General 14-Sep-2016 Completed Clinical Trials - General
5. Later Stage VC (Series D) 23-Nov-2015 Completed Clinical Trials - General
4. Later Stage VC (Series C) 01-Feb-2013 Completed Clinical Trials - General
3. Later Stage VC (Series B2) 31-Jan-2011 $5.2M $19.4M Completed Startup
2. Early Stage VC (Series B) 23-Oct-2008 $7.5M $14.2M Completed Startup
To view BAROnova’s complete valuation and funding history, request access »

BAROnova Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series E
Series D Prime
Series D
Series C
Series B2
Series B 652,375 $0.001000 8% $3.16 $3.16 1x $3.16 0.19%
Series A 2,416,667 $0.001000 8% $1.5 $1.5 1x $1.5 0.7%
To view BAROnova’s complete cap table history, request access »

BAROnova Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of nonmedical devices designed to help patients in managing their weight. The company's devices are inserted i
Therapeutic Devices
San Carlos, CA
8 As of 2020

Dallas, TX
 

Fort Lauderdale, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BAROnova Competitors (6)

One of BAROnova’s 6 competitors is EndoStim, a Venture Capital-Backed company based in Dallas, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
EndoStim Venture Capital-Backed Dallas, TX
Spatz (Therapeutic Devices) Venture Capital-Backed Fort Lauderdale, FL
REVA Medical Venture Capital-Backed San Diego, CA
EndoGastric Solutions Formerly VC-backed Redmond, WA
Allurion Technologies Formerly VC-backed Paris, France
To view BAROnova’s complete competitors history, request access »

BAROnova Patents

  • 151

    Total Documents Applications and Grants

  • Total Patents Families

  • 68

    Granted

  • Pending

  • Expiring in next 12 mo

BAROnova Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220362044-A1 Devices, assemblies, and systems for delivering and deploying a gastric obstruction device and methods of operation thereof Inactive 17-May-2021
WO-2018169805-A1 Ingestible and expandable devices and assemblies for weight-loss and methods of use thereof Inactive 11-Mar-2017
US-11083613-B2 Gastric obstruction device deployment assembly and methods of delivering and deploying a gastric obstruction device Inactive 23-Jan-2017
US-20180221186-A1 Gastric obstruction device deployment assembly and methods of delivering and deploying a gastric obstruction device Active 23-Jan-2017
US-20220023082-A1 Gastric obstruction device deployment assembly and methods of delivering and deploying a gastric obstruction device Inactive 23-Jan-2017 A61F5/0089
To view BAROnova’s complete patent history, request access »

BAROnova Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

BAROnova FAQs

  • When was BAROnova founded?

    BAROnova was founded in 2006.

  • Where is BAROnova headquartered?

    BAROnova is headquartered in San Carlos, CA.

  • What is the size of BAROnova?

    BAROnova has 8 total employees.

  • What industry is BAROnova in?

    BAROnova’s primary industry is Therapeutic Devices.

  • Is BAROnova a private or public company?

    BAROnova is a Private company.

  • What is BAROnova’s current revenue?

    The current revenue for BAROnova is .

  • How much funding has BAROnova raised over time?

    BAROnova has raised $105M.

  • Who are BAROnova’s competitors?

    EndoStim, Spatz (Therapeutic Devices), REVA Medical, EndoGastric Solutions, and Allurion Technologies are some of the 6 competitors of BAROnova.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process